Health

UK becomes first nation to approve dual-strain Covid-19 vaccine

UK becomes first nation to approve dual-strain Covid-19 vaccine

Health

The United Kingdom has reportedly become the first country to approve a dual vaccine for coronavirus, which can offer protection against the recent Omicron variant and the original SARS COV 2 strain.

The latest vaccine named Spikevax has been developed by Moderna and is called a bivalent vaccine due to its capability to target two forms of Covid.

Reportedly, the Ministers have confirmed that the jab will be a part of the autumn booster campaign, with health officials adding that people can opt for any of the booster doses offered as all of them will provide protection.

With the Covid-19 virus h

HPV vaccine could help cut risk of cervical cancer relapse: Study

HPV vaccine could help cut risk of cervical cancer relapse: Study

Health

A new study has reportedly suggested that the administration of Human Papillomavirus (HPV) vaccine could greatly benefit women who have pre-cancerous cells on their cervix by reducing the risk of relapse.

For the uninitiated, the HPV vaccine is routinely administered to children, both boys and girls, between ages 12 and 13 and helps prevent cancers caused by the human papillomavirus, such as cervical cancer, head or neck cancer, and anal cancer.

The vaccine that came into being in 2008, is not routinely offered to those who then exceeded 13 years of age. This was because several studies then found that after someone is infected with

UK: MPs warn that NHS is facing the worst workforce crisis in history

UK: MPs warn that NHS is facing the worst workforce crisis in history

Health

The National Health Service, UK’s public healthcare system, is reportedly experiencing the ‘greatest’ staffing crisis ever recorded, putting patients at a greater risk of harm, a committee of MPs has warned.

In a report by the Commons health and social care select committee, the lack of a reliable government strategy has been pointed out regarding the understaffing of the NHS. It has also criticized ministers for postponing a blueprint that the committee believes is urgent for addressing the wide gaps in each area of care.

The report also included proof that the crisis in England is worse than what official figures

Coronavirus fattens body cells to fuel viral acquisition: Study

Coronavirus fattens body cells to fuel viral acquisition: Study

Health

According to a new research study, the COVID-19 virus can increase the fat content of the patient’s body cells to power its viral invasion through the body, with the content of some fats rising up 64x their standard levels.

Scientists stated that in order to cause the infection, the COVID-19 virus takes over the fat-processing mechanism of the body by enhancing the cell’s fat-storing capacity, enabling it to seize the molecular machinery of the body and cause disease.

Keeping that in mind, scientists tried employing several fat-targeting compounds and weight-loss drugs to control the viruses spread in the cell culture. I

SaveIN teams with MyKare Health to expand BNPL services for healthcare

SaveIN teams with MyKare Health to expand BNPL services for healthcare

Health

Healthcare fintech startup, SaveIn, has reportedly entered into a partnership with MyKare Health, an asset-light healthcare chain with small- and medium-sized hospitals, to extend its buy now pay later offerings for treatment across India.

With the partnership, SaveIN will be able to expand its instant and paperless checkout finance for elective and standardized healthcare procedures across MyKareHealth’s network of hospitals. 

Jitin Bhasin, Founder and CEO of SaveIN, stated that the startup is thrilled to partner with MyKareHealth and plans to provide affordable and timely healthcare to its fast-growing customer base tha

Dostarlimab shows 100% response in treatment of dMMR rectal cancer

Dostarlimab shows 100% response in treatment of dMMR rectal cancer

Health

A clinical trial involving dostarlimab, an anti-PD-1 monoclonal antibody, has reportedly led to 100% complete responses in a group of 18 patients with advanced-stage mismatch repair-deficient (dMMR) rectal cancer, according to researchers at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York City.

According to reports, at the end of the 6-month study, no evidence of tumor came up during follow-up MRIs of 14 patients, with the follow-up ranging from 6 to 25 months where no patient received additional therapy.

Meanwhile, the rest of the four patients, who had limited follow-up, demonstrated preliminary evidence of response

Scientists begin Phase 1 human trial for new cancer-killing virus

Scientists begin Phase 1 human trial for new cancer-killing virus

Health

Scientists have reportedly administered the first human patient with a revolutionary cancer-killing virus, known as Vaxinia, which has delivered successful results during animal testing.

Now, the true test of the virus’ efficacy will begin with the new clinical trial.

It is hoped that the body’s immune response will be amplified against cancer with the virus, which has been specifically engineered to kill cancer cells.

In the last decade, such viruses had delivered very limited successes, however this time around, scientists developed this cancer-killing virus to harm cancer cells w

Cerebral under probe by DOJ over controlled substances prescription

Cerebral under probe by DOJ over controlled substances prescription

Health

Online mental health startup, Cerebral, has reportedly stated that it is being investigated by the Department of Justice (DOJ) over possible violations of the Controlled Substances Act.

In a company statement, the firm stated that it received a grand jury subpoena last week from the U.S. Attorney’s Office for the Eastern District of New York.

Under the Controlled Substances Act, the distribution of potentially addictive medicines like Xanax and Adderall is regulated.

The company clarified that currently no law enforcement or regulatory authority has accused the startup of violating any la

Psychedelic drug psilocybin can alleviate depression in brain: Study

Psychedelic drug psilocybin can alleviate depression in brain: Study

Health

A study has reportedly found that psilocybin, a psychedelic drug compound obtained from magic mushrooms, can free up the brains of those suffering from severe depression differently than how other antidepressants do.

Based on the brain scans of 60 subjects, researchers believe that the drug can treat depression among individuals in a unique way.

For the record, psychedelics are currently being studied for the treatment of various mental health disorders. However, patients suffering from depression are warned from taking psilocybin by themselves.

A synthetic form of the psychedelic is under trial unde